SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Omnicell, Inc. (OMCL) trades at a trailing P/E of 769.1, forward P/E of 20.7. Trailing earnings yield is 0.13%, forward earnings yield 4.82%. PEG 0.01 (Peter Lynch undervalued ≤1.0). Graham Number is $5.30.
Criteria proven by this page:
- VALUE (39/100, Fail) — trailing P/E is well above the S&P 500 average of ~25, suggesting a premium valuation (P/E 769.1); trailing earnings yield is below the 10-year Treasury yield (~4.3%), meaning bonds offer a better return (EY 0.13%).
- Forward P/E 20.7 (down from trailing 769.1) — analysts expect earnings to grow, which would improve the valuation.
- PEG Ratio 0.01 — below 1.0 suggests the stock is undervalued relative to its earnings growth rate (Peter Lynch criterion).
- Trailing Earnings Yield 0.13% — below bond yields — investors are paying a premium for expected growth rather than current earnings. Forward yield improves to 4.82% as earnings recover.
- Analyst consensus target $55.25 (+52.1% upside) — significant upside potential according to Wall Street analysts.
Overall SharesGrow Score: 46/100 with 0/7 criteria passed.
SharesGrow 7-Criteria Score
✗
VALUE
39/100
Price-to-Earnings & upside
Proven by this page
~
HEALTH
50/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — OMCL
Valuation Multiples
P/E (TTM)769.1
Forward P/E20.7
PEG Ratio0.01
Forward PEG0.01
P/B Ratio1.28
P/S Ratio1.35
EV/EBITDA17.5
Per Share Data
EPS (TTM)$0.05
Forward EPS (Est.)$1.75
Book Value / Share$27.40
Revenue / Share$26.35
FCF / Share$1.88
Yields & Fair Value
Earnings Yield0.13%
Forward Earnings Yield4.82%
Dividend Yield0.00%
Graham Number$5.30
SharesGrow IV$781.68 (+2051.6%)
Analyst Target$55.25 (+52.1%)
Historical Valuation
| Year |
P/E (TTM) |
PEG Ratio |
P/B Ratio |
P/S Ratio |
Dividend Yield |
| 2016 |
2,032.7 |
-29.63 |
2.84 |
1.77 |
- |
| 2017 |
88.2 |
0.44 |
3.51 |
2.54 |
- |
| 2018 |
63.7 |
3.44 |
3.54 |
3.05 |
- |
| 2019 |
55.2 |
1.02 |
4.01 |
3.78 |
- |
| 2020 |
158.8 |
-3.26 |
5.28 |
5.73 |
- |
| 2021 |
100.8 |
0.74 |
6.84 |
6.93 |
- |
| 2022 |
396.3 |
-4.27 |
1.98 |
1.73 |
- |
| 2023 |
-83.5 |
0.19 |
1.43 |
1.48 |
- |
| 2024 |
163.6 |
-1.02 |
1.65 |
1.84 |
- |
| 2025 |
1,014.7 |
-12.16 |
1.69 |
1.76 |
- |
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2016 |
$0.26 |
$692.62M |
$603K |
0.1% |
| 2017 |
$0.79 |
$716.17M |
$20.61M |
2.9% |
| 2018 |
$0.93 |
$787.31M |
$37.73M |
4.8% |
| 2019 |
$1.43 |
$897.03M |
$61.34M |
6.8% |
| 2020 |
$0.74 |
$892.21M |
$32.19M |
3.6% |
| 2021 |
$1.62 |
$1.13B |
$77.85M |
6.9% |
| 2022 |
$0.12 |
$1.3B |
$5.65M |
0.4% |
| 2023 |
$-0.45 |
$1.15B |
$-20.37M |
-1.8% |
| 2024 |
$0.27 |
$1.11B |
$12.53M |
1.1% |
| 2025 |
$0.04 |
$1.18B |
$2.05M |
0.2% |
Analyst Estimates
| Year |
EPS (Avg) |
EPS Range |
Revenue (Avg) |
Revenue Range |
Analysts |
| 2026 |
$1.75 |
$1.67 – $1.85 |
$1.24B |
$1.23B – $1.26B |
6 |
| 2027 |
$2.09 |
$1.82 – $2.49 |
$1.31B |
$1.3B – $1.33B |
6 |
| 2028 |
$2.53 |
$2.47 – $2.58 |
$1.41B |
$1.39B – $1.44B |
1 |
